DeviceTalks Boston has ended
Wednesday, June 17 • 4:00pm - 5:30pm
Regulatory Session: Maximizing Your Clinical Investment

Sign up or log in to save this to your schedule and see who's attending!

Regulatory/Clinical Session: Maximizing Your Clinical InvestmentIndustry Thought Leaders will discuss utilizing clinical, regulatory, and scientific communication strategies to get the most out of your clinical investment. Panelists will discuss using a multi-pronged approach to clinical development opportunities. Topics covered include, but are not limited to:
  • Steps required to maximize market adoption of your new technology
  • Creating out of the box regulatory strategies that address not only regulatory, but marketing and business needs.
  • Risks and benefits of pursuing general versus specific indication for approval
  • How and when to strategically prepare for publications/scientific evidence and trials that might be required for reimbursement and market adoption.
  • What are the boundaries around promotion? Methods to balance the conservatism of regulatory considerations with the promotion of your product
  • Early medical communication strategies to maximize scientific investments and boost marketing and sales

avatar for Jeannette  Bankes

Jeannette Bankes

Vice President, Global Clinical Research, Communications and Medical Education, Boston Scientific Corp.
24+ years of experience in medical devices and pharmaceuticals 11 years of experience in medical device industry, primarily focused in clinical research and medical affairs 13 years of experience in pharmaceutical industry at Merck & Co. Diverse career portfolio... Read More →

avatar for Eric Ankerud

Eric Ankerud

Executive Vice President, Clinical, Regulatory and Quality, Ocular Therapeutix
Eric Ankerud has more than 25 years of product approval experience covering a wide range of pharmaceuticals, medical devices, and biologics. He joined Ocular Therapeutix in 2007, also serving as Executive Vice President, Clinical, Regulatory and Quality at a sister company Augmenix... Read More →
avatar for Melissa Clark

Melissa Clark

Managing Director, Halloran Consulting
Melissa joined Halloran Consulting Group in 2011. She has 19 years of experience in successful planning and execution of regulatory strategies and clinical trial programs for new product development, developing quality systems, and managing regulatory due diligence and integration... Read More →
avatar for Linda Levitt

Linda Levitt

Senior Director Scientific Communications; Covidien Group at Medtronic, Covidien

Wednesday June 17, 2015 4:00pm - 5:30pm
Boston Scientific Global Headquarters

Attendees (0)